Serum markers of ovarian reserve and ovarian histology in adult mice treated with cyclophosphamide in pre-pubertal age

Journal of Assisted Reproduction and Genetics

Volumn 30, Issue 11, 2013, Pages 1421-1429

  Detti, Laura ^a   Uhlmann, Rebecca A ^a   Lu, Meifen ^b   Diamond, Michael P ^c   Saed, Ghassan M ^d   Fletcher, Nicole M ^d   Zhang, Jie ^b   Williams, Lucy J ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Department of Pathology ^*  (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AMH; Animal study; Cyclophosphamide; Follicle count; FSH; Prepubertal

Indexed keywords

CYCLOPHOSPHAMIDE; FOLLITROPIN; FORMALDEHYDE; MARKER; PARAFFIN; PLACEBO;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; MOUSE; NONHUMAN; OVARIAN HISTOLOGY; OVARIAN RESERVE; OVARY; OVARY INSUFFICIENCY; PRIORITY JOURNAL;

ANIMALIA; MUS;

ANIMALS; ANTI-MULLERIAN HORMONE; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BIOLOGICAL MARKERS; CYCLOPHOSPHAMIDE; FEMALE; FOLLICLE STIMULATING HORMONE; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; OVARY; SEXUAL MATURATION;

EID: 84890540457     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-013-0087-x     Document Type: Article

References (28)

1. Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003;18:2368-74.
2. Browne HN, Moon KS, Mumford SL, et al. Is anti-Müllerian hormone a marker of acute cyclophosphamide-induced ovarian follicular destruction in mice pretreated with cetrorelix? Fertil Steril. 2011;96:180-6.
3. Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006;91:1723-8.
4. de Bruin JP, Dorland M, Spek ER, et al. Ultrastructure of the resting ovarian follicle pool in healthy young women. Biol Reprod. 2002;66:1151-60.
5. de Vet A, Laven JS, de Jong FH, Themmen APN, Fauser BC. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77:357-62.
6. Decanter C, Morschhauser F, Pigny P, Lefebvre C, Gallo C, Dewailly D. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results. Reprod Biomed Online. 2010;20:280-5.
7. Detti L, Martin DC, Williams RD, Schlabritz-Loutsevich N, Williams LJ, Uhlmann RA. Somatic and reproductive outcomes in mice treated with cyclophosphamide in pre-pubertal age. Syst Biol Reprod Med. 2013;59:140-5.
8. Di Clemente N, Goxe B, Remy JJ, et al. Inhibitory effect of AMH upon aromatase activity and LH receptors of granulosa cells of rat and porcine immature ovaries. Endocrine. 1994;2:553-8.
9. Durlinger ALL, Kramer P, Karels B, et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinol. 1999;140:5789-96.
10. Durlinger ALL, Visser JA, Themmen APN. Regulation of ovarian function: the role of anti-Mullerian hormone. Reprod. 2002;124:601-9.
11. Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003;18:323-7.
12. Green DM, Sklar CA, Boice Jr JD, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2374-81.
13. Kevenaar ME, Meerasahib MF, Kramer P, et al. Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinol. 2006;147:3228-34.
14. Kline JK, Kinney AM, Levin B, Kelly AC, Ferin M, Warburton D. Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis. Hum Reprod. 2011;26:1537-50.
15. Meirow D, Nugent D. (2001) The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7:535-43.
16. Ohnemus U, Unalan M, Handjiski B, Paus R. Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage. J Invest Dermatol. 2004;122:7-13.
17. Oktay K, Briggs D, Gosden RG. Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab. 1997;82:3748-51.
18. Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer. 2007;110:2222-9.
19. Oktem O, Oktay K. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res. 2007;67:10159-62.
20. Pepling ME, Spradling AC. Mouse ovarian germ cell cysts undergo programmed breakdown to form primordial follicles. Dev Biol. 2001;234:339-51.
21. Sahambi SK, Visser JA, Themmen AP, Mayer LP, Devine PJ. Correlation of serum anti-Mullerian hormone with accelerated follicle loss following 4-vinyl-cyclohexene diepoxide-induced follicle loss in mice. Reprod Toxicol. 2008;26:116-22.
22. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87:3045-52.
23. Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr. 1997;130:210-6.
24. Tingen CM, Bristol-Gould SK, Kiesewetter SE, Wellington JT, Shea L, Woodruff TK. Prepubertal primordial follicle loss in mice is not due to classical apoptotic pathways. Biol Reprod. 2009;81:16-25.
25. Vaskivuo TE, Anttonen M, Herva R, et al. Survival of human ovarian follicles from fetal to adult life: apoptosis, apoptosis-related proteins, and transcription factor GATA-4. J Clin Endocrinol Metab. 2001;86:3421-9.
26. Vialard F, Boitrelle F, Molina-Gomes D, Selva J. Predisposition to aneuploidy in the oocyte. Cytogenet Genome Res. 2011;133:127-35.
27. Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Müllerian hormone: a new marker for ovarian function. Reprod. 2006;131:1-9.
28. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62:738-44.